436 related articles for article (PubMed ID: 38009668)
21. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential.
Luo ZD; Wang YF; Zhao YX; Yu LC; Li T; Fan YJ; Zeng SJ; Zhang YL; Zhang Y; Zhang X
World J Gastroenterol; 2023 Jan; 29(1):1-18. PubMed ID: 36683709
[TBL] [Abstract][Full Text] [Related]
22. EBV miR-BARTs and human lncRNAs: Shifting the balance in competing endogenous RNA networks in EBV-associated gastric cancer.
Torres K; Landeros N; Wichmann IA; Polakovicova I; Aguayo F; Corvalan AH
Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166049. PubMed ID: 33401001
[TBL] [Abstract][Full Text] [Related]
23. Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer.
Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
[TBL] [Abstract][Full Text] [Related]
24. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression.
Chen DL; Lu YX; Zhang JX; Wei XL; Wang F; Zeng ZL; Pan ZZ; Yuan YF; Wang FH; Pelicano H; Chiao PJ; Huang P; Xie D; Li YH; Ju HQ; Xu RH
Theranostics; 2017; 7(19):4836-4849. PubMed ID: 29187907
[TBL] [Abstract][Full Text] [Related]
26. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m
Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y
Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145
[TBL] [Abstract][Full Text] [Related]
27. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis.
Chen Z; Wu J; Huang W; Peng J; Ye J; Yang L; Yuan Y; Chen C; Zhang C; Cai S; He Y; Wu S; Song W
Cell Physiol Biochem; 2018; 47(6):2432-2444. PubMed ID: 29991048
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation.
Yu Y; Li L; Zheng Z; Chen S; Chen E; Hu Y
J Cell Mol Med; 2017 May; 21(5):955-967. PubMed ID: 27878953
[TBL] [Abstract][Full Text] [Related]
29. Non-coding RNAs regulate tumor cell plasticity.
Liu B; Sun L; Song E
Sci China Life Sci; 2013 Oct; 56(10):886-90. PubMed ID: 24091685
[TBL] [Abstract][Full Text] [Related]
30. Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment.
Si L; Yang Z; Ding L; Zhang D
J Cancer Res Clin Oncol; 2022 Mar; 148(3):547-564. PubMed ID: 35083552
[TBL] [Abstract][Full Text] [Related]
31. Non-coding RNAs regulating epithelial-mesenchymal transition: Research progress in liver disease.
Yang X; Jiang Z; Li Y; Zhang Y; Han Y; Gao L
Biomed Pharmacother; 2022 Jun; 150():112972. PubMed ID: 35447551
[TBL] [Abstract][Full Text] [Related]
32. The expression of long non-coding RNA LINC01389, LINC00365, RP11-138J23.1, and RP11-354K4.2 in gastric cancer and their impacts on EMT.
Taghehchian N; Farshchian M; Mahmoudian RA; Asoodeh A; Abbaszadegan MR
Mol Cell Probes; 2022 Dec; 66():101869. PubMed ID: 36208698
[TBL] [Abstract][Full Text] [Related]
33. The value of exosome-derived noncoding RNAs in colorectal cancer proliferation, metastasis, and clinical applications.
Zhang W; Jiang Z; Tang D
Clin Transl Oncol; 2022 Dec; 24(12):2305-2318. PubMed ID: 35921060
[TBL] [Abstract][Full Text] [Related]
34. An epigenetic modulator with promising therapeutic impacts against gastrointestinal cancers: A mechanistic review on microRNA-195.
Davoodvandi A; Rafiyan M; Asemi Z; Matini SA
Pathol Res Pract; 2023 Aug; 248():154680. PubMed ID: 37467635
[TBL] [Abstract][Full Text] [Related]
35. The ncRNA-TGF-β axis: Unveiling new frontiers in colorectal cancer research.
Alharbi KS
Pathol Res Pract; 2024 Feb; 254():155138. PubMed ID: 38266458
[TBL] [Abstract][Full Text] [Related]
36. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
Liang Y; Zhang CD; Zhang C; Dai DQ
Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
[TBL] [Abstract][Full Text] [Related]
37. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Fanale D; Barraco N; Listì A; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
[TBL] [Abstract][Full Text] [Related]
38. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
Fanale D; Castiglia M; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
[TBL] [Abstract][Full Text] [Related]
39. Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance.
Hashemi M; Hasani S; Hajimazdarany S; Mirmazloomi SR; Makvandy S; Zabihi A; Goldoost Y; Gholinia N; Kakavand A; Tavakolpournegari A; Salimimoghadam S; Nabavi N; Zarrabi A; Taheriazam A; Entezari M; Hushmandi K
Int J Biol Macromol; 2022 Dec; 222(Pt A):1151-1167. PubMed ID: 36191781
[TBL] [Abstract][Full Text] [Related]
40. Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications.
Khanbabaei H; Ebrahimi S; García-Rodríguez JL; Ghasemi Z; Pourghadamyari H; Mohammadi M; Kristensen LS
J Exp Clin Cancer Res; 2022 Sep; 41(1):278. PubMed ID: 36114510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
